CVAC
Price
$3.30
Change
+$0.02 (+0.61%)
Updated
Feb 21 closing price
Capitalization
740.32M
59 days until earnings call
HNSBF
Price
$3.00
Change
+$0.17 (+6.01%)
Updated
Dec 31 closing price
Capitalization
139.38M
Ad is loading...

CVAC vs HNSBF

Header iconCVAC vs HNSBF Comparison
Open Charts CVAC vs HNSBFBanner chart's image
CureVac
Price$3.30
Change+$0.02 (+0.61%)
Volume$1.16M
Capitalization740.32M
Hansa Medical AB
Price$3.00
Change+$0.17 (+6.01%)
Volume$500
Capitalization139.38M
CVAC vs HNSBF Comparison Chart
Loading...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVAC vs. HNSBF commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVAC is a Hold and HNSBF is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (CVAC: $3.30 vs. HNSBF: $3.00)
Brand notoriety: CVAC and HNSBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVAC: 127% vs. HNSBF: 54%
Market capitalization -- CVAC: $740.32M vs. HNSBF: $139.38M
CVAC [@Biotechnology] is valued at $740.32M. HNSBF’s [@Biotechnology] market capitalization is $139.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVAC’s FA Score shows that 1 FA rating(s) are green whileHNSBF’s FA Score has 0 green FA rating(s).

  • CVAC’s FA Score: 1 green, 4 red.
  • HNSBF’s FA Score: 0 green, 5 red.
According to our system of comparison, CVAC is a better buy in the long-term than HNSBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVAC’s TA Score shows that 3 TA indicator(s) are bullish.

  • CVAC’s TA Score: 3 bullish, 6 bearish.

Price Growth

CVAC (@Biotechnology) experienced а -9.59% price change this week, while HNSBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

CVAC is expected to report earnings on May 21, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CVAC($740M) has a higher market cap than HNSBF($139M). HNSBF YTD gains are higher at: 0.000 vs. CVAC (-3.226). CVAC has higher annual earnings (EBITDA): 166M vs. HNSBF (-616.54M). CVAC has more cash in the bank: 555M vs. HNSBF (405M). CVAC has less debt than HNSBF: CVAC (40.1M) vs HNSBF (1.08B). CVAC has higher revenues than HNSBF: CVAC (543M) vs HNSBF (171M).
CVACHNSBFCVAC / HNSBF
Capitalization740M139M532%
EBITDA166M-616.54M-27%
Gain YTD-3.2260.000-
P/E Ratio6.69N/A-
Revenue543M171M318%
Total Cash555M405M137%
Total Debt40.1M1.08B4%
FUNDAMENTALS RATINGS
HNSBF: Fundamental Ratings
HNSBF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CVAC
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
76%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 19 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
69%
Aroon
ODDS (%)
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FOXA56.95-0.43
-0.75%
Fox Corp
CSCI2.72-0.02
-0.91%
COSCIENS Biopharma Inc
DCOM30.59-0.53
-1.70%
Dime Community Bancshares
SCPH3.25-0.11
-3.27%
scPharmaceuticals
EGO13.41-1.26
-8.59%
Eldorado Gold Corp

CVAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CVAC has been loosely correlated with BNTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CVAC jumps, then BNTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVAC
1D Price
Change %
CVAC100%
+0.61%
BNTX - CVAC
43%
Loosely correlated
+1.81%
MDGL - CVAC
42%
Loosely correlated
-4.22%
ARCT - CVAC
42%
Loosely correlated
+5.02%
MRNA - CVAC
41%
Loosely correlated
+5.34%
AXON - CVAC
39%
Loosely correlated
-5.28%
More

HNSBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HNSBF has been loosely correlated with ENSC. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if HNSBF jumps, then ENSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSBF
1D Price
Change %
HNSBF100%
N/A
ENSC - HNSBF
33%
Loosely correlated
-4.09%
CVAC - HNSBF
33%
Poorly correlated
+0.61%
MLLCF - HNSBF
27%
Poorly correlated
N/A
ALLK - HNSBF
27%
Poorly correlated
-1.72%
GNPX - HNSBF
25%
Poorly correlated
-0.61%
More